OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer.

Research

OncoResponse

OncoResponse's headquarters in Seattle, WA, United States

Clifford J. Stocks

Kamal D. Puri

Chris Russell

Sean A. McCarthy

Miriam Merad

Mike Gallatin

Wende Hutton

Anil Singhal

Michael A. Curran

James W. Welsh

David Hong

Steven Gillis

John McKearn

Roberto De Ponti

Ted Koutouzis

David G. Denardo

Carol Gallagher

Description

People (4)

Clifford J. Stocks

Kamal D. Puri

Chris Russell

Myriam Bouchlaka

Jobs